Ep 272 - Widening MedTech’s Wars Against Migraines, Cardiac Fibrillation

In this episode of DeviceTalks Weekly, Rob Binney, CEO of ShiraTronics, explains how the neurostimulation device is working to provide some relief for people suffering from chronic migraines. Binney’s career started in pharma, but he’s built a MedTech career at significant companies including AccessClosure, Intersect ENT before taking his first CEO role at Alydia Health. In our FOMO interview, Steven Mickelsen, MD, chief technology officer and founder of Field Medical, details the different challenges in taking on ventricular cardiac arrhythmias vs. atrial fibrillation where he built his monumental success. Dr. Mickelsen will also share Field Medical’s story at our DeviceTalks Cardiac Innovations Series taking place Feb 3-5. Register at DeviceTalks.com to watch live or on demand. MassDevice’s Chris Newmarker brings his Newmarker’s Newsmakers – Johnson & Johnson MedTech, Edwards Lifesciences, Distalmotion, Intuitive Surgical, Medtronic, and Boston Scientific. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:12) - Distalmotion secures funding from J&J to support Dexter rollout in ASCs(00:06:43) - Edwards gives up on $1.2B JenaValve acquisition(00:09:00) - Intuitive says daVinci systems ‘exceeded expectations,’ it wants more(00:11:12) - Medtronic has ‘significant firepower’ to boost M&A(00:13:08) - All the big news from Boston Scientific(00:20:10) - FOMO – Steven Mickelsen, MD, Founder, Field Medical(00:27:40) - Keynote Interview, Rob Binney, CEO, ShiraTronics